Report #2825826

Overview

Sex

Male

Age

Age unknown

State

IN

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

A 55 years old male patient received a dose of manevo; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administered by other route in a 55-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number X4T99, expiry date 30-SEP-2025) for prophylaxis. On an unknown date, the patient received Menveo (subcutaneous). On an unknown date, an unknown time after receiving Menveo, the patient experienced intramuscular formulation administered by other route (Verbatim: A 55 years old male patient received a dose of manevo). The outcome of the intramuscular formulation administered by other route was unknown. Additional Information: GSK Receipt Date: 05-FEB-2025 The pharmacist reported that they administered a dose of Menveo (1 vial) subcutaneously instead of intramuscularly, which led to intramuscular formulation administered by other route. The reporter was ask what was the recommendations to follow.